Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |